WeightWatchers prices its clinical tier at $25 for the first month, then $74 a month. Set beside the telehealth figures in this category — $79, $129, $139 — it looks like the cheapest way to get a GLP-1 prescribed and supervised.
It is not on the same scale as those numbers, because it does not contain a drug. WeightWatchers says so on the plan card itself.
Every figure below was read from ww.com on 2026-09-09. This page reports published prices and the terms attached to them; it does not recommend a medicine or a programme, as our editorial standards set out.
The sentence that decides the comparison
The MED+ plan card describes what the fee buys in six words: "Access to medication, clinical care, and coaching."
Directly beneath it, on the same card: "GLP-1 meds cost not included."
Both statements are true and they are not in conflict, but the first is easy to misread as the second's opposite. Access to medication means a clinician who can assess, prescribe and monitor. It does not mean the medication arrives. The drug is bought separately, at whatever the pharmacy, insurer or manufacturer programme charges, and at current self-pay rates it is several times the size of the membership fee.
This is the whole answer to "what does a WeightWatchers GLP-1 cost", and everything else on this page is detail behind it.
What the membership costs on its own
| 12-month plan | 6-month plan | |
|---|---|---|
| First month | $25 | $25 |
| Each month after | $74 | $84 |
| Cost of the term | $839 | $445 |
| Renews as | another 12 months at $74 | another 6 months at $84 |
| Renewed term costs | $888 | $504 |
| Medication | not included | not included |
The site's footnote is the source for all of it:
$25 for your first month with a 12-month or 6-month plan. After the first month, membership continues for $74/mo (12-month plan) or $84/mo (6-month plan) for the remainder of your applicable plan term. Cost of GLP-1 medications not included. Plans auto-renew for another 12-month or 6-month period at the same monthly rate at the end of each plan term.
Two features of that are worth pulling out.
The $74 is a committed rate, not a rolling one. It exists inside a 12-month plan term. The cheaper monthly number is the reward for the longer commitment, which is a perfectly ordinary way to price a subscription — but it means the advertised figure and a cancel-anytime figure are not the same offer.
The renewal is for another whole term. Not another month: "another 12-month or 6-month period at the same monthly rate." Someone who lets a 12-month plan lapse into renewal has committed to a second year, not to a second month. Cancelling a monthly subscription and exiting a fixed term are different operations with different consequences, and the difference sits in a footnote.
The pattern repeats across every tier
The introductory rate is not the renewal rate anywhere on this page.
The CORE plan is advertised "Starting at $12 /month". CORE+ states that the "Plan auto renews at the end of the plan term for another 12 month period at $22 a month unless canceled." And the banner across the top — "50% off with a 12-month plan" — carries its own asterisk: "Pricing based on a 12-month commitment. Plan auto-renews at the end of each plan term for another 12-month period unless canceled."
So the structure is consistent from the cheapest tier to the clinical one: a discounted entry price, a 12-month commitment, and an automatic renewal at a rate that is not the entry price. None of it is hidden and all of it is in smaller type than the number it qualifies.
Who provides the medical care
Not the consumer brand. The footnote states: "All medical services provided through our affiliated medical group, Weight Watchers Clinic."
This is the same management-services arrangement used across US telehealth, and it exists because most states restrict corporate ownership of medical practices. It is not a mark against the company. It is worth knowing for the same reason it is worth knowing elsewhere in this category: the entity taking the payment and the entity carrying the clinical responsibility are formally distinct.
The trial on the page measures diet quality, not weight
The plans page cites a randomised controlled trial, which is more than most consumer weight-loss marketing does and deserves credit. It also deserves reading.
Based on a 6-month randomized controlled trial (n=376) that compared participants following WW to those given standard nutritional guidelines alone. WW members increased their Healthy Eating Index score by 5.31 points, compared to 1.13 points with standard guidance. Palacios et al. Effectiveness of a digital weight management program on diet quality: a randomized controlled trial. AJCN. 2025. Funded by WW International, Inc.
The outcome is the Healthy Eating Index, a measure of how closely a diet matches dietary guidelines. It is a legitimate endpoint and the trial is a real randomised study. It is not a weight-loss result, the title of the paper says so, and the citation discloses that the sponsor funded it.
A second claim on the same page — the one about doctors recommending the programme — is sourced to "a 2023 survey by Cerner Enviza of 500 doctors who recommend weight-loss programs to patients." That is market research. Both citations are disclosed accurately; they simply support narrower claims than a quick read suggests.
What to compare it against
The useful comparison is not $74 against another provider's monthly figure. It is $74 plus a drug against another provider's figure, and then a check on whether that figure already contains one.
Where the medication is bought separately, the manufacturer self-pay routes are usually the reference point, and their headline prices come with conditions that change the real number — the detail is on our GLP-1 cost page, with the brand-level terms for Zepbound, Wegovy, Mounjaro and Ozempic.
Where a provider quotes a single figure that includes a medicine, the thing to establish is which medicine — a branded, approved product and a compounded preparation are different categories priced very differently, as the arithmetic in our Mochi Health review shows.
Judged on what it is rather than what the number looks like, WeightWatchers MED+ is a coaching and clinical-supervision subscription with a prescriber attached, sold on an annual commitment, with the drug billed elsewhere. That may be good value for someone who wants the behavioural programme and has a separate route to the medication. It is not the cheapest monthly GLP-1 price on the market, and it was never claiming to be.